Comparison between Effwa Infra IPO and Nephro Care IPO.
Effwa Infra IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Nephro Care IPO is a SME Bookbuilding proposed to list at NSE SME.
Effwa Infra IPO | Nephro Care IPO | |
---|---|---|
Logo | ![]() | ![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Bookbuilding | Bookbuilding |
Listing At | NSE SME | NSE SME |
Lead Managers | Shreni Shares Ltd. | Corporate Capitalventures Pvt.Ltd. |
Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
Market Maker | Rikhav Securities Ltd. | SS Corporate Securities Ltd. |
DRHP | DRHP ![]() | DRHP ![]() |
RHP | RHP ![]() | RHP ![]() |
Anchor Investor | Anchor Investor ![]() | Anchor Investor ![]() |
IPO Allotment URL | IPO Allotment URL ![]() | IPO Allotment URL ![]() |
The total issue size of Effwa Infra IPO is up to ₹48.61 Cr whereas the issue size of the Nephro Care IPO is up to ₹39.18 Cr. The final issue price of Effwa Infra IPO is ₹82.00 per share and of Nephro Care IPO is ₹90.00 per share.
Effwa Infra IPO | Nephro Care IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹78.00 per share | ₹85.00 per share |
Issue Price (Upper) | ₹82.00 per share | ₹90.00 per share |
Issue Price (Final) | ₹82.00 per share | ₹90.00 per share |
Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
Discount (Employee) | ₹0.00 per share | |
Market Lot Size | 1600 shares | 1600 shares |
Fresh Issue Size | 49,92,000 shares | 43,53,600 shares |
Fresh Issue Size (Amount) | up to ₹40.93 Cr | up to ₹39.18 Cr |
OFS Issue Size | 9,36,000 shares | 0 shares |
OFS Issue Size (Amount) | up to ₹7.68 Cr | up to ₹0.00 Cr |
Issue Size Total | 59,28,000 shares | 43,53,600 shares |
Issue Size Total (Amount) | up to ₹48.61 Cr | up to ₹39.18 Cr |
Effwa Infra IPO opens on Jul 05, 2024, while Nephro Care IPO opens on Jun 28, 2024. The closing date of Effwa Infra IPO and Nephro Care IPO is Jul 09, 2024, and Jul 02, 2024, respectively.
Effwa Infra IPO | Nephro Care IPO | |
---|---|---|
Anchor Bid Date | Jul 04, 2024 | Jun 27, 2024 |
Issue Open | Jul 05, 2024 | Jun 28, 2024 |
Issue Close | Jul 09, 2024 | Jul 02, 2024 |
Basis Of Allotment (Tentative) | Jul 10, 2024 | Jul 03, 2024 |
Initiation of Refunds (Tentative) | Jul 11, 2024 | Jul 04, 2024 |
Credit of Share (Tentative) | Jul 11, 2024 | Jul 04, 2024 |
Listing date (Tentative) | Jul 12, 2024 | Jul 05, 2024 |
Anchor Lockin End date 1 | Aug 09, 2024 | Aug 02, 2024 |
Anchor Lockin End date 2 | Oct 08, 2024 | Oct 01, 2024 |
Effwa Infra IPO P/E ratio is 10.59, as compared to Nephro Care IPO P/E ratio of 55.15.
Effwa Infra IPO | Nephro Care IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financials | Effwa Infra & Research Limited Financial Information (Restated)Effwa Infra & Research Limited's revenue increased by 26.08% and profit after tax (PAT) rose by 169% between the financial year ending with March 31, 2024 and March 31, 2023.
| Nephro Care India Limited Financial Information (Restated)Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.99 | 85.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 72.99 | 61.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 10.59 | 55.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹189.81 Cr. | ₹148.38 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 45.46% | 41.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 40.99% | 36.56% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.38 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹7.74 | ₹1.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 37.15% | 24.42% |
In the Effwa Infra IPO Retail Individual Investors (RII) are offered 20,91,200 shares while in Nephro Care IPO retail investors are offered 20,91,200 shares. Qualified Institutional Buyers (QIB) are offered 11,68,000 shares in Effwa Infra IPO and 8,25,600 shares in Nephro Care IPO.
Effwa Infra IPO | Nephro Care IPO | |
---|---|---|
Anchor Investor Reserveration | 17,48,800 shares | 12,38,400 shares |
Market Maker Reserveration | 3,24,800 shares | 2,30,400 shares |
QIB | 11,68,000 shares | 8,25,600 shares |
NII | 9,20,000 shares | 6,19,200 shares |
RII | 20,91,200 shares | 14,44,800 shares |
Employee | 2,25,600 shares | |
Others | ||
Total | 59,28,000 shares | 43,53,600 shares |
Effwa Infra IPO subscribed 313.65x in total, whereas Nephro Care IPO subscribed 715.78x.
Effwa Infra IPO | Nephro Care IPO | |
---|---|---|
QIB (times) | 166.56x | 245.14x |
NII (times) | 477.27x | 1,787.19x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 323.81x | 634.12x |
Employee (times) | ||
Other (times) | ||
Total (times) | 313.65x | 715.78x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O